Literature DB >> 21946434

A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection.

Xiaohui Wang1, Chris C S Chan, Min Yang, Jun Deng, Vincent K M Poon, Virtual H C Leung, King-Hung Ko, Jie Zhou, Kwok Yung Yuen, Bo-Jian Zheng, Liwei Lu.   

Abstract

Interleukin-17 (IL-17), a member of the IL-17 cytokine family, plays a crucial role in mediating the immune response against extracellular bacteria and fungi in the lung. Although there is increasing evidence that IL-17 is involved in protective immunity against H1 and H3 influenza virus infections, little is known about the role of IL-17 in the highly pathogenic H5N1 influenza virus infection. In this study, we show that H5N1-infected IL-17 knockout (KO) mice exhibit markedly increased weight loss, more pronounced lung immunopathology and significantly reduced survival rates as compared with infected wild-type controls. Moreover, the frequency of B cells in the lung were substantially decreased in IL-17 KO mice after virus infection, which correlated with reduced CXCR5 expression in B cells and decreased CXCL13 production in the lung tissue of IL-17 KO mice. Consistent with this observation, B cells from IL-17 KO mice exhibited a significant reduction in chemokine-mediated migration in culture. Taken together, these findings demonstrate a critical role for IL-17 in mediating the recruitment of B cells to the site of pulmonary influenza virus infection in mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946434      PMCID: PMC4012931          DOI: 10.1038/cmi.2011.38

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  49 in total

1.  CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity.

Authors:  K Mark Ansel; Ruth B S Harris; Jason G Cyster
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

2.  Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

Authors:  Kyle I Happel; Mingquan Zheng; Erana Young; Lee J Quinton; Euan Lockhart; Alistair J Ramsay; Judd E Shellito; Jill R Schurr; Gregory J Bagby; Steve Nelson; Jay K Kolls
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

3.  Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology.

Authors:  J S Oxford
Journal:  Rev Med Virol       Date:  2000 Mar-Apr       Impact factor: 6.989

4.  IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement.

Authors:  Bainan Liu; Weihong Tan; Adel Barsoum; Xiaogang Gu; Kong Chen; Weitao Huang; Alistair Ramsay; Jay K Kolls; Paul Schwarzenberger
Journal:  Exp Hematol       Date:  2010-06-19       Impact factor: 3.084

5.  Proinflammatory T helper type 17 cells are effective B-cell helpers.

Authors:  Meike Mitsdoerffer; Youjin Lee; Anneli Jäger; Hye-Jung Kim; Thomas Korn; Jay K Kolls; Harvey Cantor; Estelle Bettelli; Vijay K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

6.  Distinct and overlapping roles of CXCR5 and CCR7 in B-1 cell homing and early immunity against bacterial pathogens.

Authors:  Uta E Höpken; Ariel H Achtman; Kerstin Krüger; Martin Lipp
Journal:  J Leukoc Biol       Date:  2004-06-14       Impact factor: 4.962

7.  The development of inducible bronchus-associated lymphoid tissue depends on IL-17.

Authors:  Javier Rangel-Moreno; Damian M Carragher; Maria de la Luz Garcia-Hernandez; Ji Young Hwang; Kim Kusser; Louise Hartson; Jay K Kolls; Shabaana A Khader; Troy D Randall
Journal:  Nat Immunol       Date:  2011-06-12       Impact factor: 25.606

8.  B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection.

Authors:  N Baumgarth; O C Herman; G C Jager; L E Brown; L A Herzenberg; J Chen
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

9.  Unmutated immunoglobulin M can protect mice from death by influenza virus infection.

Authors:  Yuichi Harada; Masamichi Muramatsu; Toshikatsu Shibata; Tasuku Honjo; Kazumichi Kuroda
Journal:  J Exp Med       Date:  2003-06-09       Impact factor: 14.307

10.  Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Authors:  P Ye; F H Rodriguez; S Kanaly; K L Stocking; J Schurr; P Schwarzenberger; P Oliver; W Huang; P Zhang; J Zhang; J E Shellito; G J Bagby; S Nelson; K Charrier; J J Peschon; J K Kolls
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

View more
  43 in total

1.  IL-17A expression in HIV-specific CD8 T cells is regulated by IL-4/IL-13 following HIV-1 prime-boost immunization.

Authors:  Jayashree Ravichandran; Ronald J Jackson; Shubhanshi Trivedi; Charani Ranasinghe
Journal:  J Interferon Cytokine Res       Date:  2014-12-10       Impact factor: 2.607

Review 2.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

Review 3.  N-3 polyunsaturated fatty acids modulate B cell activity in pre-clinical models: Implications for the immune response to infections.

Authors:  Jarrett Whelan; Kymberly M Gowdy; Saame Raza Shaikh
Journal:  Eur J Pharmacol       Date:  2015-05-27       Impact factor: 4.432

4.  Lung γδ T Cells Mediate Protective Responses during Neonatal Influenza Infection that Are Associated with Type 2 Immunity.

Authors:  Xi-Zhi J Guo; Pradyot Dash; Jeremy Chase Crawford; E Kaitlynn Allen; Anthony E Zamora; David F Boyd; Susu Duan; Resha Bajracharya; Walid A Awad; Nopporn Apiwattanakul; Peter Vogel; Thirumala-Devi Kanneganti; Paul G Thomas
Journal:  Immunity       Date:  2018-08-28       Impact factor: 31.745

Review 5.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

Review 6.  H5N1 pathogenesis studies in mammalian models.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Virus Res       Date:  2013-02-28       Impact factor: 3.303

7.  Single-Cell Transcriptomic Analysis of SARS-CoV-2 Reactive CD4 + T Cells.

Authors:  Benjamin J Meckiff; Ciro Ramírez-Suástegui; Vicente Fajardo; Serena J Chee; Anthony Kusnadi; Hayley Simon; Alba Grifoni; Emanuela Pelosi; Daniela Weiskopf; Alessandro Sette; Ferhat Ay; Grégory Seumois; Christian H Ottensmeier; Pandurangan Vijayanand
Journal:  SSRN       Date:  2020-07-07

8.  The interaction of influenza H5N1 viral hemagglutinin with sialic acid receptors leads to the activation of human γδ T cells.

Authors:  Yanlai Lu; Zhen Li; Chi Ma; Hao Wang; Jing Zheng; Lianxian Cui; Wei He
Journal:  Cell Mol Immunol       Date:  2013-08-05       Impact factor: 11.530

9.  Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytes.

Authors:  Hao Wang; Chi Ma; Yanlai Lu; Xu Ji; Yongsheng Pang; Fang Hua; Lianxian Cui; Denian Ba; Wei He
Journal:  Cell Mol Immunol       Date:  2013-08-05       Impact factor: 11.530

Review 10.  Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders.

Authors:  Keven M Robinson; Michelle L Manni; Partha S Biswas; John F Alcorn
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.